Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 4/20 | 0.66 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.66 |
| ▸ | ECE1 | P42892 | 1/20 | 0.66 |
| ▸ | CPB1 | P15086 | 1/20 | 0.62 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.62 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.59 |
| ▸ | ACE | P12821 | 1/20 | 0.59 |
| ▸ | SIRT2 | Q8IXJ6 | 3/20 | 0.58 |
| ▸ | SIRT1 | Q96EB6 | 3/20 | 0.58 |
| ▸ | SIRT3 | Q9NTG7 | 2/20 | 0.58 |
| ▸ | DPP4 | P27487 | 2/20 | 0.58 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.57 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.57 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.57 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.57 |
| ▸ | TLR2 | O60603 | 2/20 | 0.56 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL287474 | 1.00 | ITGB3 (0.66) | ITGB3ITGA2BECE1CPB1CPB2 | |
| SCHEMBL15968143 | 1.00 | ITGB3 (0.66) | ITGB3ITGA2BECE1CPB1CPB2 | |
| SCHEMBL287475 | 1.00 | ITGB3 (0.66) | ITGB3ITGA2BECE1CPB1CPB2 | |
| Hydrochloric Acid SCHEMBL4994643 | 0.99 | ITGB3 (0.65) | ITGB3ITGA2BECE1CPB1CPB2 | |
| SCHEMBL29733071 | 0.99 | ITGB3 (0.65) | ITGB3ITGA2BECE1CPB1CPB2 | |
| Hydrochloric Acid SCHEMBL11310715 | 0.99 | ITGB3 (0.65) | ITGB3ITGA2BECE1CPB1CPB2 | |
| Hydrochloric Acid SCHEMBL21219335 | 0.99 | ITGB3 (0.65) | ITGB3ITGA2BECE1CPB1CPB2 | |
| Monoethanolamine SCHEMBL9496843 | 0.96 | ITGB3 (0.62) | ITGB3ITGA2BECE1CPB1CPB2 | |
| Glycine SCHEMBL28708677 | 0.96 | ITGB3 (0.62) | ITGB3ITGA2BECE1CPB1CPB2 | |
| SCHEMBL2367228 | 0.96 | ITGB3 (0.64) | ITGB3ITGA2BECE1CPB1CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3246048-B1 | BI-FUNCTIONAL CO-POLYMER USE FOR OPHTHALMIC APPLICATIONS | CALM WATER THERAPEUTICS LLC (US) | 2024-04-03 | — | — | EP | claimed |
| CN-115090225-A | Novel efficient aldehyde-removing transparent gel and preparation method thereof | 重庆中科力泰高分子材料股份有限公司 | 2022-09-23 | — | — | CN | claimed |
| US-20260062446-A1 | SCALABLE SYNTHESIS OF ANABAENOPEPTINS | WAYNE STATE UNIVERSITY (US) | 2026-03-05 | — | — | US | disclosed |
| US-20250241943-A1 | BI-FUNCTIONAL CO-POLYMER USE FOR OPHTHALMIC AND OTHER TOPICAL AND LOCAL APPLICATIONS | CALM WATER THERAPEUTICS LLC | 2025-07-31 | — | — | US | disclosed |
| CN-113527217-B | Diketopiperazine compound and application thereof | 上海惠永药物研究有限公司 | 2025-05-23 | — | — | CN | disclosed |
| CN-119875130-A | Polyethylene glycol modified polylysine, preparation method thereof, nano vaccine and application | 中国科学院长春应用化学研究所 | 2025-04-25 | — | — | CN | disclosed |
| CN-113527216-B | Preparation method of diketopiperazine compound, intermediate thereof and preparation method thereof | 上海惠永药物研究有限公司 | 2025-03-21 | — | — | CN | disclosed |
| EP-4426353-A2 | METHODS FOR USING BIOADHESIVE AND STERIC INTERACTIONS OF COPOLYMERS TO MINIMIZE ADVERSE EFFECTS | Calm Water Therapeutics LLC (US) | 2024-09-11 | — | — | EP | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| WO-2024177424-A1 | NOVEL IONIZABLE LIPID AND LIPID NANOPARTICLE CONTAINING SAME | 에스티팜 주식회사 | 2024-08-29 | — | — | WO | disclosed |
| EP-3246048-B1 | BI-FUNCTIONAL CO-POLYMER USE FOR OPHTHALMIC APPLICATIONS | CALM WATER THERAPEUTICS LLC (US) | 2024-04-03 | — | — | EP | disclosed |
| WO-2001014316-A1 | SUBSTITUTED CHIRAL ALLOSTERIC HEMOGLOBIN MODIFIERS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2001-03-01 | — | — | WO | disclosed |
| US-5885816-A | OPTICALLY RESOLVING A RACEMIC MIXTURE OF AMINO ACID DERIVATIVES, COMPRISING USING A NONSPECIFIC CATALYTIC ANTIBODY WHICH ENANTIOSELECTIVELY HYDROLIZES VARIOUS AMINO ACID ESTER DERIVATIVES | PROTEIN ENGINEERING RESEARCH INSTITUTE (JP) | 1999-03-23 | — | — | US | disclosed |
| EP-0765940-A1 | CATALYTIC ANTIBODY WHICH HYDROLYZES AMINO ACID ESTER DERIVATIVE ENANTIOSELECTIVELY | PROTEIN ENGINEERING RESEARCH INSTITUTE (JP) | 1997-04-02 | — | — | EP | disclosed |
| EP-0680469-A1 | AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME | Dr. Karl Thomae GmbH (DE) | 1995-11-08 | — | — | EP | disclosed |
| WO-1994017035-A1 | AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME | DR. KARL THOMAE GMBH (DE) | 1994-08-04 | — | — | WO | disclosed |
| EP-0097031-B1 | NONAPEPTIDE AND DECAPEPTIDE ANALOGS OF LHRH USEFUL AS LHRH ANTAGONISTS, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | SYNTEX (U.S.A.) INC. (US) | 1988-09-21 | — | — | EP | disclosed |
| EP-0145258-B1 | NONAPEPTIDE AND DECAPEPTIDE ANALOGS OF LHRH, USEFUL AS LHRH AGONISTS, AND PROCESSES FOR THEIR PREPARATION | SYNTEX (U.S.A.) INC. (US) | 1987-04-15 | — | — | EP | disclosed |
| EP-0145258-A1 | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH agonists, and processes for their preparation | SYNTEX (U.S.A.) INC. (US) | 1985-06-19 | — | — | EP | disclosed |
| EP-0097031-A2 | Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists, their preparation and compositions containing them | SYNTEX (U.S.A.) INC. (US) | 1983-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062446-A1 | SCALABLE SYNTHESIS OF ANABAENOPEPTINS | AQP1, PTMS, CHAMP1 | ITGB3 4831/4885ITGA2B 4813/4885ECE1 1637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.